NIR light may identify breast cancer patients who will benefit most from chemotherapy


02/14/2018 12:28 PM EST

cross sections of a breast with a tumor

A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings from a first pilot study of the new imaging system — a noninvasive method of measuring blood flow dynamics in response to a single breath hold — were published today in Radiology.

Full story at

Columbia University School of Engineering and Applied Science

This is an NSF News From the Field item.